Regenerative Medicine Market Forecast by 2023: Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic Plc.
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023.
View full press release